Differential modulation of nociceptive responses to mu and kappa opioid receptor directed drugs by blood glucose in experimentally induced diabetes rats

Indian Journal of Experimental Biology

Volumn 38, Issue 3, 2000, Pages 242-248

  Tandon, Monika ^a   Srivastava, R K ^a   Nagpal, R K ^a   Khosla, P ^a   Singh, J ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; PENTAZOCINE;

ANIMAL; ARTICLE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; METABOLISM; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; BUPRENORPHINE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HYPERGLYCEMIA; MORPHINE; PAIN MEASUREMENT; PENTAZOCINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

ANIMALIA;

EID: 0034008588     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Morley G K, Mooradian A D, Levine A S & Morley J E, Mechanism of pain in diabetic peripheral neuropathy. Am J Med, 77 (1984) 79.
2. Levine A S, Morley J E, Wicox G, Brown D M & Handwerger B S, Tailpinch behaviour and analgesia in diabetic mice, Physiol Behav, 28 (1982) 39.
3. Simon G S & Dewey W L, Narcotics and diabetes I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine. J Pharmacol Exp Ther, 218 (1981) 318.
4. Simon G S, Borzelleca J & Dewey W L, Narcotics and diabetes II. Streptozotocin-induced diabetes selectively alters the potency of certain narcotic analgesics. Mechanism of diabetes - Morphine interaction. J Pharmacol Exp Ther, 218 (1981) 324.
5. Raz I, Hasdai D, Seltzer Z & Melwed R N, Effect of hyperglycaemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes, 37 (1988) 1253.
6. Chu P C, Lin M T, Shian L R & Lev S Y, Alterations in physiologic functions and in brain monoamine content in streptozotocin - diabetic rats. Diabetes, 35 (1986) 481.
7. Davis W M, Miya T S & Edward L D, The influence of glucose and insulin pretreatment upon morphine analgesia in the rat. J Am Pharm Assoc, 45 (1956) 60.
8. Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H & Kasuya Y, Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu-1 opioid receptors but not that by mu-2 opioid receptors. Neurosci Lett, 165 (1994) 141.
9. Trinder P, Enzymatic determination of blood glucose. Ann Clin Biochem, 6 (1969) 24.
10. 1A receptor mediated activity. J Pharmacol Exp Ther, 256 (1991) 973.
11. Geislor G J Jr & Liebeskind J C, Inhibition of visceral pain by electrical stimulation of periaqueductal gray matter. Pain 2 (1976) 43.
12. Forman L J, Estilow S, Lewis M & Vasilenko P, Streptozotocin diabetes alters immunoreactive-endorphin levels and pain perception after 8 weeks in female rats. Diabetes, 35 (1986) 1309.
13. Morley J E, Levine A S, Brown D B & Handwerger B S, Evidence for in vivo and in vitro modulation of the opiate receptor by glucose. Soc Neuro Sci Abstr, 7 (1981) 854.
14. Forman L J, Marquis D E, Stevens R, Adler R & Vasilenko P, Diabetes induced by streptozotocin results in a decrease in immunoreactive β-endorphin levels in the pituitary and hypothalamus of female rats. Diabetes, 34 (1985) 1104.
15. Locatelli V, Petralgia F, Tirloni N & Muller E E, Beta-endorphin concentration in the hypothalamus, pituitary and plasma of streptozotocin diabetic rats with and without insulin substitution. Life Sci, 38 (1986) 379.
16. Abrams G M & Recht L, Neuropeptides and their role in pain and analgesia. Acupunct Electro-Ther Res, 7 (1982) 105.
17. Bitar M, Koulu M, Rapoport S & Linnoila M, Diabetes-induced alterations in brain monoamine metabolism in rats. J Pharmacol Exp Ther, 236 (1986) 432.
18. Roane D S & Paul D, Evidence of hyperglycaemic hyperalgesia by Quinpirole. Pharmacol Biochem Behav, 41 (1992) 65.
19. Strother A, Effect of glucose on enzyme activity and duration of drug action. Fed Proc, 38 (1979) 366.
20. Marshall J F, Further analysis of the resistance of the diabetic rat to d-amphetamine. Pharmacol Biochem Behav, 8 (1978) 281.
21. Fernando J C R & Curzon G, Effect of d-amphetamine on tryptophan and other aromatic amino acids in the brain. Eur J Pharmacol, 49 (1978) 339.
22. MacKenzie R G, &. Trulson M E, Effects of insulin and streptozotocin-induced diabetes on brain tryptophan and serotonin metabolism in rats, J Pharm Pharmacol, 30 (1978) 131.
23. Takemori A E, Pharmacologic factors which alter the action of narcotic analgesics. Ann NY Acad Sci, 281 (1976) 262.
24. Sharma K K & Sen P, in Recent progress in chemistry and biology of centrally acting peptides, edited by B N, Dhawan, R S Rapaka (Central Drug Research Institute, Lucknow), 1988, 175.
25. Kamei J, Iwamoto Y, Misawa M, Nagase H & Kasuya Y, Effects of diabetes on the antinociceptive effect of pentazocine in mice. Res Commun Chem Pathol Pharmacol, 84 (1994) 105.
26. Kamei J, Ohhashi Y, Aoki T, Kawashima N & Kasuya Y, Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists but not by delta and kappa-opioid agonists. Brain Res, 571 (1992) 199.
27. Kamei J, Kawashima N & Kasuya Y, Serum glucose level dependent and independent modulation of mu-opioid agonist mediated analgesia in diabetic mice. Life Sci, 52 (1993) 53.
28. Medbak S, Mason D F & Rees L H, Plasma, met-enkephalin and catecholamine responses to insulin induced hypoglycaemia in grey hounds. J Endocrinol, 114 (1987) 81.
29. Singh I S, Chaterjee T K & Ghosh J J, Modification of morphine antinociceptive response by blood glucose status: Possible involvement of cellular energetics, Eur J Pharmacol, 90 (1983) 437.
30. + channels, Science, 247 (1990) 852.
31. Voigtlander P F, Lewis R A & Neff G L, K opioid analgesia is dependent on serotonergic mechanisms, J Pharmacol Exp Ther, 231 (1984) 270.
32. Wera M A & MacDonald R L, Opioid peptides selective for μ and δ-opiate receptors reduce calcium - dependent action potential duration by increasing potassium conductance. Neurosci Lett, 42 (1983) 173.
33. Wild K D, Vanderah T, Mosberg H I & Porreca F, Opioid δ receptor subtypes are associated with different potassium channels. Eur J Pharmacol, 193 (1991) 135.
34. Narita M, Suzuki T, Misawa M, Nagare H, Nabeshima A, Aishizawa T, Ozawall, Saito T & Takahata N, Role of central ATP-sensitive potassium channels in the analgesic effect and spinal noradrenaline turnover-enhancing effect of intracerebroventricularly injected morphine in mice. Brain Res, 596 (1992) 209.